Sir Gangaram Hospital, Harvard Medical School collaborate to assist India in COVID related diseases

A statement issued by SGRH today read, "The Massachusetts General Hospital (MGH), Harvard Medical School, USA and Sir Gangaram Hospital (SGRH), New Delhi collaborated to improve the quality of healthcare providers in India's response to Covid and Covid related diseases (like mucormycosis)."

Published On 2021-05-25 03:45 GMT   |   Update On 2021-05-25 11:36 GMT
Advertisement

New Delhi: The Massachusetts General Hospital (MGH), Harvard Medical School, USA have collaborated with Delhi's Sir Gangaram Hospital (SGRH) with an aim to improve the quality of healthcare providers in India and enhance infrastructure to combat Covid-related diseases like Mucormycosis, informed SGRH on Monday.

This comes at a time when the country is witnessing rising cases of Mucormycosis, commonly known as black fungus, a post-Covid complication.

Advertisement

Also Read:Double dose of COVID vaccines effective against India variant, says English health officials

A statement issued by SGRH today read, "The Massachusetts General Hospital (MGH), Harvard Medical School, USA and Sir Gangaram Hospital (SGRH), New Delhi collaborated to improve the quality of healthcare providers in India's response to Covid and Covid-related diseases (like mucormycosis)."

Cases of Covid patients from India whose management is instructive to many providers across the country are presented and discussed by experts at MGH and SGRH in order to educate and improve the quality of care and spur ideas for future research, said the hospital.

The hospital further informed that under the collaboration that has kicked off during the second wave of the pandemic, doctors from both hospitals have discussed the appropriate and efficient use of high-tech interventions like extra-corporeal membrane oxygenation (ECMO) as well as the treatment and prevention (by curbing over-treatment with steroids and controlling of diabetes) of mucormycosis, black fungus.

This is done on a Zoom, currently weekly webinar where listeners can participate, it added.

Also Read:Hearing Loss reported after COVID Vaccination, though infrequently

Tags:    
Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News